Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Alcohol use disorder (AUD) imposes a significant global health burden, yet effective treatments remain limited due to the scarcity of well-characterized biological sample repositories. To address this gap, we established the UCSD Alcohol BioBank, a comprehensive resource containing thousands of samples from over 700 genetically diverse heterogeneous stock (HS) rats. Modeled after successful cocaine and oxycodone biobanks, this repository utilizes the chronic intermittent ethanol vapor exposure (CIE) model, paired with oral self-administration, to characterize AUD-like behaviors, including ethanol consumption, preference, motivation, and withdrawal symptoms such as allodynia and anxiety-like behavior. Longitudinal samples (blood, urine, and feces) are collected before, during, and after ethanol exposure, while terminal samples (brain, heart, liver, kidneys, cecum, reproductive organs, adrenal glands, peripheral blood mononuclear cells) are obtained at intoxication, acute withdrawal, protracted abstinence, or from naive controls. Samples are preserved via snap-freezing or paraformaldehyde fixation to support diverse applications, including genomics, transcriptomics, proteomics, and neuroanatomy. The genetic diversity of HS rats enables genome-wide association studies (GWAS) to identify AUD-related genetic variants. Freely available to non-profit organizations at www.alcoholbiobank.org, with genetic and behavioral data deposited in public repositories, the Alcohol BioBank facilitates collaborative research to uncover biomarkers and develop novel therapies for AUD, addressing a critical need in addiction science.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12247670PMC
http://dx.doi.org/10.1101/2025.04.30.651600DOI Listing

Publication Analysis

Top Keywords

alcohol biobank
12
samples
5
preclinical alcohol
4
biobank samples
4
samples behaviorally
4
behaviorally characterized
4
characterized rats
4
rats aud
4
aud alcohol
4
alcohol disorder
4

Similar Publications

Tattoos and permanent make-up (PMU) gain increasing popularity among the general population. There are indications that pigments or their fragments may translocate within the body, however knowledge about possible systemic adverse effects related to tattoos is very limited. We investigated the prevalence of systemic chronic health effects including cardiovascular diseases, cancer and liver toxicity and their relationship with the presence and characteristics of tattoos and PMU as part of the LIFE-Adult-study, a population-based cohort study.

View Article and Find Full Text PDF

Introduction: Knockout of the Fmo5 gene in mice led to a lean, slow-ageing phenotype characterised by the presence of 2,3-butanediol isomers in their urine and plasma. Oral treatment of wildtype mice with 2,3-butanediol led to a low cholesterol, low epididymal fat phenotype.

Objectives: Determine if significant, heterozygous coding variations in human FMO5 would give rise to similar clinical and metabolic phenotypes in humans, as in C57BL/6J mice with knockout of the Fmo5 gene and in particular, increased excretion of 2,3-butanediol.

View Article and Find Full Text PDF

The influence of metabolic dysfunction on depressive symptom trajectories: A one-year follow-up study.

J Affect Disord

September 2025

Département de psychiatrie et d'addictologie, Université de Montréal, Montréal, Québec, Canada; Centre de recherche de l'Institut universitaire en santé mentale (CR-IUSMM), Université de Montréal, Montréal, Québec, Canada.

This study explored the role of metabolic syndrome (MetS) and health-related behaviors in the progression of depressive symptoms over a one-year naturalistic follow-up in patients with depressive disorder. Using data from 153 participants recruited through the Signature Biobank at a psychiatric emergency setting, we tested whether MetS mediated the relationship between health-related behaviors such as smoking, alcohol and drug use, and sleep, and depressive symptom trajectories. Linear mixed models revealed that while depressive symptoms significantly decreased over time, higher MetS score was associated with a slower improvement in depressive symptoms.

View Article and Find Full Text PDF

The role of intrinsic capacity in predicting cancer mortality - Evidence from the UK Biobank.

Maturitas

August 2025

Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Navarra, Spain; CIBER of Frailty and Healthy Aging (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.

Aim: To examine the association between intrinsic capacity and cancer mortality in middle-aged and older adults.

Methods: We analysed a prospective cohort of 443,130 participants from the UK Biobank, with seven biomarkers reflecting the level of functioning in five domains of intrinsic capacity to calculate an overall score (ranging from 0 [better] to +4 [poor]). Associations between intrinsic capacity scores and mortality from any type of cancer (censored as of December 31, 2022) were estimated using Cox proportional hazard models adjusted for multiple potential confounders.

View Article and Find Full Text PDF

Plasma proteomic signatures accurately predict disease risk, but our understanding of the mechanisms contributing to the predictive value of the proteome remains limited. Here, we characterized proteomic biomarkers of 19 age-related diseases, based on observational associations between 2,923 protein levels and incidence of these outcomes in the UK Biobank (N = 45,438). To identify the subset of these biomarkers that may represent causal drivers of disease, we first employed Mendelian Randomization (MR) and found that only 8% of the protein-disease associations with genetic instruments showed suggestive evidence of causal relationships, and were more likely to pertain to only a single disease.

View Article and Find Full Text PDF